Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q2 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
VTR:US | Ventas Inc. | Common share | - | US92276F1003 | $59.58 |
Company name | Ventas |
---|---|
Tags | #reit, #s&p500 index |
Sector | Real Estate / Real Estate / Equity Real Estate Investment Trusts (REITs) / Health Care REITs |
Business address | 353 N. CLARK STREET SUITE 3300 CHICAGO IL 60654 3126603800 |
Mailing address | 353 N. CLARK STREET SUITE 3300 CHICAGO IL 60654 |
Website | ir.ventasreit.com |